TrialJAMA oncology2023

Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.

Julien Mazieres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.